Medicamentos de actualidad = Drugs of today

• 

  Año 2018, Vol. 54, Número 4

  • MONOGRAPHS

    • Daclatasvir, asunaprevir and beclabuvir fixed-dose combination for patients with genotype 1 chronic hepatitis C.

      Abdoulaye Thiam, B. Conway

      • Resumen

      págs. 237-244

      

    • Eravacycline for the treatment of patients with bacterial infections.

      Ritesh P. Thakare, Arunava Dasgupta, Sidharth Chopra

      • Resumen

      págs. 245-254

      

    • Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection.

      B.B. Summers

      • Resumen

      págs. 255-268

      

  • REVIEW

    • Recombinant factor VIII: past, present and future of treatment of hemophilia A.

      S. Raso, C. Hermans

      • Resumen

      págs. 269-282

      

  • INSIGHT

    • The opioid crisis: a 21st century pain.

      G. Walker

      • Resumen

      págs. 283-286

      

  • NEW PRODUCT INTROS

    • New product intros (nalotimagene carmaleucel, sargramostim [new indication], elobixibat [first-in-class]).

      pág. 287